"Thyroglobulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D013954
|
MeSH Number(s) |
D12.776.377.856 D12.776.395.768 D12.776.486.706
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thyroglobulin".
Below are MeSH descriptors whose meaning is more specific than "Thyroglobulin".
This graph shows the total number of publications written about "Thyroglobulin" by people in this website by year, and whether "Thyroglobulin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1997 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2000 | 0 | 2 | 2 |
2005 | 2 | 0 | 2 |
2006 | 1 | 1 | 2 |
2007 | 2 | 0 | 2 |
2008 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
2020 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyroglobulin" by people in Profiles.
-
Predicting factors and clinical outcome of biochemical incomplete response in middle eastern differentiated thyroid carcinoma. Endocrine. 2024 Oct; 86(1):268-275.
-
Persistent or Recurrent Disease in Thyroid Cancer Survivors Who Have Elevated Serum Antithyroglobulin Antibodies. Endocr Pract. 2023 Jun; 29(6):436-440.
-
Response to Ros?rio and Souza C?rtes re: "The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence". Thyroid. 2020 11; 30(11):1686-1687.
-
The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence. Thyroid. 2020 10; 30(10):1490-1495.
-
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv. 2019 05 14; 3(9):1441-1449.
-
Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry. Thyroid. 2019 04; 29(4):530-539.
-
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab. 2018 10 01; 103(10):3698-3705.
-
Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):410-5.
-
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid. 2014 Jan; 24(1):35-42.
-
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma. Thyroid. 2011 Dec; 21(12):1309-16.